Spectral Med Inc faced a significant drop in its stock price during yesterday's trading session.
Spectral Med Inc (EDT.TO) saw its stock price fall by 7.63% yesterday, closing at CA$1.09. This decline raises concerns for investors who have been watching the company’s progress in the medical field.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$346.39M
52W high
$1.65
52W low
$1.13
1W change
-15.50%
Beta
0.18
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 189.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+189.0% Upside
Current Price
C$1.09
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
37.7%
Annualized
90-Day Vol
29.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.91
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.03 | C$0.90 – C$1.17 |
| 60 trading days | C$0.97 | C$0.80 – C$1.16 |
| 90 trading days | C$0.91 | C$0.73 – C$1.14 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as Spectral Med Inc's stock shows volatility, reflecting broader uncertainties in its market performance.
Spectral Med Inc sees a 7.63% drop in stock price
The drop in stock price brings Spectral Med Inc's market cap down to CA$319.97 million, highlighting investor concerns.
Bull case
Despite the recent downturn, Spectral Med Inc has potential due to its ongoing FDA approval processes and advancements in medical technology. Investors may find hope in the company’s commitment to innovation and the possibility of future growth as it works toward regulatory approvals.
Bear case
The recent decline in stock price may signal underlying issues or a general skepticism among investors about the company's future. Concerns about its ability to deliver on promises could weigh heavily on investor sentiment, especially given the current market conditions.
Recent Performance Overview
Advertisement
In yesterday's trading session, Spectral Med Inc's stock fell sharply by 7.63%. This decline is particularly concerning given the company's recent efforts to secure FDA approval for its PMX therapy. Investors may be reacting to the lack of immediate positive developments or updates from the company.
Market Reaction and Investor Sentiment
The significant drop in stock price could suggest that investors are becoming increasingly wary of Spectral Med Inc's ability to deliver on its promises. With a market cap of CA$319.97 million, the company's valuation may be under scrutiny, especially in light of its recent financial results and updates regarding FDA applications.
Looking Ahead
As Spectral Med Inc continues to navigate the complexities of the medical approval process, investors should keep a close eye on any forthcoming announcements. The company's future performance will likely depend on its ability to reassure the market about its growth potential and the viability of its products.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
